Free Trial

Summit Therapeutics (SMMT) SEC Filings & 10K Form

$8.68
-2.23 (-20.43%)
(As of 05/31/2024 ET)

Recent Summit Therapeutics SEC Filings

DateFilerForm TypeView
05/30/2024
3:48 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:35 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:48 AM
Summit Therapeutics (Filer)
Form 424B5
05/01/2024
7:45 AM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:11 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
8:21 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
8:19 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2024
3:35 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
4:52 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:43 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2024
4:47 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:42 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:27 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:28 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:36 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
02/20/2024
6:55 AM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/20/2024
7:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:32 AM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:35 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2024
3:08 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
8:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:19 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:22 PM
Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:24 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:16 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:11 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:49 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:08 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:06 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:08 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
6:46 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
2:40 PM
Summit Therapeutics (Filer)
Form DEF 14A
08/09/2023
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
3:05 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:43 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s arrest is phase one (Ad)

In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election…

To get all the details, go here now.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SMMT) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners